Behandlingsrelaterede bivirkninger som ” hjertesvigt ”, ” kronisk venstresidigt hjerteinsufficiens ” eller ” venstre ventrikelsvigt ” ses hos 0, 7% af patienterne med solide tumorer og hos 1% af patienterne, der
Treatment-related adverse events of ‘ cardiac failure’, ‘ cardiac failure congestive’ or ‘ left ventricular failure’ were reported in 0.7% of patients with solid tumours and 1% of patients treated with placebo.